Rare diseases
Investigational molecules
Locations
Avinguda De Barcelona 69, 08970 Sant Joan Despi, Spain
Clinical research includes multiple sclerosis with attention to oral disease-modifying therapy and gastrointestinal tolerability in healthy volunteers. The sponsor’s portfolio in this area reflects interest in dimethyl fumarate and related fumarate-based treatments.
These studies focus on treatment-related tolerability and comparative assessment of oral therapies used in neurological disease.
Neuraxpharm Pharmaceuticals S.L. runs clinical trials in conditions such as Anxiety, Delirium tremens, Epilepsy, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
PortugalComparison of oxazepam 50 mg orodispersible tablets and oxazepam 50 mg standard tablets in healthy volunteers to test if they work the same way in the body
PortugalStudy on the Bioequivalence of Oxazepam 10 mg Orodispersible Tablets Compared to Standard Tablets in Healthy Volunteers
PortugalStudy on the Effectiveness and Safety of Levetiracetam XR for Patients with Drug-Resistant Partial Onset Epilepsy
BulgariaIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
